Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question

The duty of who to include on a proxy rests with the BoD so there is therefore no requirement to include nominees just because they have been proposed.

Last year the SEC proposed rule changes to the procedure, which I have previously posted.

.

.

.

Be well

Share
New Message
Please login to post a reply